Flunarizine 5 mg (Generic)

Product Overview

Flunarizine 5 mg is a generic prescription medication manufactured by Cipla Limited, a globally recognized pharmaceutical company with a strong reputation for quality and regulatory compliance. The product is formulated as a preventive therapy specifically for migraine and is supplied in a convenient strip containing ten tablets. Pack sizes are available in 30, 60, and 90 tablets, each tablet delivering a consistent 5 mg dose of flunarizine. Orders are typically processed and shipped within six to fifteen days, depending on the destination and selected shipping option.

What is Flunarizine 5 mg (Generic)

Flunarizine belongs to the class of dihydrobenzodioxine derivatives and functions primarily as a selective antagonist at the serotonin 5‑HT_1B/1D receptors while also blocking L‑type calcium channels in neuronal membranes. The generic formulation contains the same active pharmaceutical ingredient as the proprietary brand, offering patients an equally effective yet cost‑effective option for migraine prophylaxis. It is indicated for the long‑term prevention of migraine attacks and is not intended for the acute treatment of a migraine that has already started.

Uses and Benefits

When taken regularly as prescribed, Flunarizine reduces the frequency of migraine episodes, often decreasing the number of migraine days per month by a substantial margin in clinical trials. Patients frequently report fewer severe attacks, improved ability to concentrate at work or school, and better overall quality of life. In addition to its preventive effect, the medication may help stabilize mood and sleep patterns, which are commonly disrupted by chronic migraine. The consistent 5 mg dose provides predictable pharmacokinetics, allowing clinicians to plan treatment duration with confidence.

How It Works

The therapeutic action of Flunarizine is rooted in its dual mechanism of vascular and neuronal modulation. By inhibiting calcium influx through L‑type channels, the drug stabilizes the excitability of cortical neurons, thereby reducing the likelihood of cortical spreading depression — a wave of neuronal depolarization that is thought to trigger migraine aura and pain pathways. Simultaneously, antagonism at the 5‑HT_1B/1D receptors attenuates the release of pro‑inflammatory neuropeptides such as calcitonin gene‑related peptide (CGRP), which plays a central role in migraine pathophysiology. This combined effect produces a sustained prophylactic benefit when the medication is maintained at therapeutic plasma levels.

Dosage Guidelines

For most adult patients, the recommended starting dose is one 5 mg tablet taken once daily, preferably in the evening, to minimize the risk of gastrointestinal irritation. The tablet should be swallowed whole with a full glass of water and can be taken with or without food, although taking it with a small meal may improve tolerability for some individuals. After a treatment period of four to six weeks, the prescribing clinician will assess the patient’s response; if migraine frequency has decreased adequately, the current dose may be continued for up to six months or longer under medical supervision.

If a dose is missed, the patient should take it as soon as remembered unless it is close to the time of the next scheduled dose; in that case, the missed dose should be skipped and the regular dosing schedule resumed. The medication should be stored at room temperature, away from moisture and heat, and kept out of reach of children. Patients should not alter the dosage without consulting their healthcare provider, and abrupt discontinuation is discouraged because it may reduce the preventive effect.

Side Effects

Most individuals tolerate Flunarizine well, but like all pharmaceutical agents, it can produce adverse reactions. The most frequently reported side effects include modest weight gain, occasional fatigue, and mild gastrointestinal discomfort such as nausea or abdominal bloating. Less common but clinically important effects may involve depressive symptoms, dizziness, or extrapyramidal signs such as tremor or rigidity. In rare cases, patients may experience allergic skin reactions or hepatic enzyme elevations, which warrant immediate medical evaluation. It is essential for patients to monitor their symptoms and report any new or worsening side effects to their physician promptly.

Warnings and Precautions

Flunarizine is contraindicated in patients with a known hypersensitivity to the drug or any of its excipients, as well as in individuals with a history of severe depression, Parkinson’s disease, or uncontrolled movement disorders. Caution is advised in patients with cardiovascular conditions, particularly those with a prolonged QT interval on electrocardiography, as the medication has been associated with rare cardiac arrhythmias. Concomitant use with other serotonergic agents, such as certain antidepressants or triptans, should be reviewed by a healthcare professional to avoid potential pharmacokinetic interactions. Pregnant or breastfeeding women should only use Flunarizine if the benefits clearly outweigh the risks, and a thorough discussion with a qualified clinician is required.

For additional regulatory information, consult the National Institutes of Health (NIH) migraine fact sheet and the FDA drug labeling database, which provide detailed guidance on indications, contraindications, and safety considerations.

Frequently Asked Questions

Q: Can Flunarizine be used to treat an ongoing migraine attack?
A: No. Flunarizine is a preventive medication and should be taken daily to reduce the frequency of migraines. Acute migraine attacks are best managed with specific abortive therapies such as triptans, NSAIDs, or gepants, as prescribed by a clinician.

Q: How long does it typically take to notice a reduction in migraine frequency?
A: Most patients observe a measurable decrease in migraine days after four to six weeks of consistent dosing. Full therapeutic effect may require up to three months, after which the clinician can evaluate whether continuation is appropriate.

Q: Is Flunarizine safe for elderly patients?
A: Clinical experience supports its use in older adults, but clinicians often start with the standard dose and monitor for side effects such as dizziness or increased fall risk. Adjustments are not routinely required, but close observation is recommended.

Q: Does Flunarizine interact with alcohol?
A: Moderate alcohol consumption is generally considered safe, but excessive intake may exacerbate drowsiness or contribute to weight gain. Patients should discuss their alcohol use with their prescribing physician.

Q: Where can I purchase Flunarizine 5 mg online?
A: Flunarizine is available through licensed online pharmacies that require a valid prescription. Ensure the pharmacy adheres to regulatory standards, sources authentic Cipla Limited products, and provides clear information about shipping timelines and storage requirements.

Related Products

• Ciplox 750mg (Ciprofloxacin)
• Diclofenac SR 100 mg
• Reactin 50 mg (Diclofenac)
• Cromal Forte Eye Drop (Sodium Cromoglycate)
• Alendronic Acid 35 mg (Generic)
• Rizact 5 mg (Rizatriptan)
• Warf 1 mg (Warfarin)
• Warf 2 mg (Warfarin)
• Warf 3 mg (Warfarin)
• Mucinac 200 mg (Acetylcysteine)
• Temozolomide 20 mg (Generic)
• Prandial 0.3 MD (Voglibose)